Publication | Closed Access

A novel indazolo-triazolo-benzotriazepine exerts anti-inflammatory effects by inhibition of cyclooxygenase-2 activity and nitric oxide synthase-2 expression

InflammationMedicinal ChemistryAnti-inflammatoryPharmacological StudyPharmacologyPharmacological AgentPharmacotherapyCyclooxygenase-2 ActivityMedicineSynthase-2 Expression